This study is currently not recruiting participants.

A Phase III Multi-Center Randomized Double-Masked Active- and Placebo-Controlled Study of Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma

Study on Investigational Medication for Ocular Hypertension or Primary Open-Angle Glaucoma

Not Recruiting
18 years - 100 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to gather information about an investigational drug called trabodenoson which was found to increase the outflow capabilities of the eye in a Phase 2 study in patients with OHT or POAG.

Detailed description of study

The purpose of this study is to gather information about an investigational drug called trabodenoson which was found to increase the outflow capabilities of the eye in a Phase 2 study in patients with Ocular Hypertension or Primary Open-Angle Glaucoma.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ocular Hypertension
  • Age: 18 years - 100 years
  • Gender: All

This study investigates an investigational medication that may help increase the fluid outflow in the eyes of patients. The study focuses on individuals with Ocular Hypertension (OHT) or Primary Open-Angle Glaucoma (POAG), which are conditions that can affect eye pressure and vision.

Participants in this study will undergo procedures to assess the effectiveness of the investigational medication in managing their eye conditions. These procedures are designed to measure changes in eye pressure and fluid outflow.

  • Who can participate: Individuals diagnosed with Ocular Hypertension or Primary Open-Angle Glaucoma may be eligible to participate. Specific age criteria and other factors are not specified, or it is open to all ages if applicable.
  • Study details: Participants will receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine. The study will involve regular monitoring of eye health.
Updated on 19 Feb 2024. Study ID: 1601523120

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team